Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MALANOSE first-in-human intranasal artesunate phase 1 study
PACTR202408719575384Phase 1Not yet recruiting
- Sponsor
- Université des Sciences, des Techniques et des Technologies de Bamako
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of artesunate in malaria (3 arms), sponsored by Université des Sciences, des Techniques et des Technologies de Bamako. Primary endpoint: Pharmacokinetic parameters of intranasal artesunate. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
artesunate
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202408719575384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202408719575384.